← Back to Search

PSMA PET/CT Scan for Prostate Cancer

Phase 3
Recruiting
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2.5 hours after tracer injection
Awards & highlights

Study Summary

This trial will test if 18F-PSMA-1007 PET/CT imaging is safe and effective in adults with prostate cancer.

Who is the study for?
This trial is for adults with prostate cancer who've had surgery or other treatments like radiotherapy, and now have rising PSA levels or high-risk features indicating possible metastatic disease. It's also open to those where a PET/CT scan might help in their care as decided by certain specialists in Alberta.Check my eligibility
What is being tested?
The study tests the safety and effectiveness of a new imaging tracer called 18F-PSMA-1007 used in PET/CT scans. It aims to improve detection of prostate cancer spread, especially evaluating non-specific bone lesions to see if they're benign or malignant.See study design
What are the potential side effects?
Possible side effects include reactions at the injection site, general discomfort post-injection, and any delayed adverse events within a week after receiving the tracer which participants are instructed to report.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2.5 hours after tracer injection
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2.5 hours after tracer injection for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Non-specific bone lesion assessment (NSBLs)
Safety - delayed
Safety - immediate
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: 18F-PSMA-1007Experimental Treatment1 Intervention
18F-PSMA-1007, 4 MBq/kg (max 400 MBq; +/- 15%), intravenous, single dose

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
898 Previous Clinical Trials
384,683 Total Patients Enrolled
9 Trials studying Prostate Cancer
2,754 Patients Enrolled for Prostate Cancer
~1867 spots leftby Dec 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top